IL6 and plasma cell myeloma: IL-6 involvement is observed in the early stages of the disease, where the myeloma interacts with the stroma and it plays a crucial role in cancer cell survival; thus, hypothetically, anti-IL-6 therapy in the early stages of the disease may have promising results [46].